Actos 15 TAKEDA

48.00

Description

Actos 15 TAKEDA: Overview and Purpose

Actos 15 TAKEDA is a pharmaceutical product that contains the active ingredient pioglitazone, primarily used for managing type 2 diabetes. This medication assists in regulating blood glucose levels by enhancing insulin sensitivity in the body. It belongs to the thiazolidinedione class of drugs, which target insulin action in muscle and fat tissues, leading to improved metabolic control. With an available form of 15 mg, Actos is a reliable option for individuals seeking to maintain stable blood sugar levels while minimizing the risk of diabetic complications.

Understanding Pioglitazone: Components and Composition

The effectiveness of Actos 15 TAKEDA can be attributed to its key ingredient and the structural formulation involved. Below are the crucial components of this medication:

  • Active Substance: Pioglitazone hydrochloride, which serves as the primary active component.
  • Chemical Name: 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, reflecting its complex molecular structure.
  • Formula: C19H20N2O3S, indicating the precise arrangement of atoms that constitute the drug.
  • Substance Class: Thiazolidinedione, categorizing its pharmacological properties.

These components are formulated to optimize the therapeutic potential of the drug while ensuring safety during your treatment journey.

Actos 15 TAKEDA: Safety Information and Precautions

While Actos 15 TAKEDA is effective for managing blood sugar levels, it is essential to be aware of potential side effects and precautions associated with its use.

  • Weight Gain: Patients may experience an increase in body weight due to fluid retention.
  • Edema: Some individuals may retain fluids, causing swelling in various body parts.
  • Heart Failure: There is a known risk of heart failure, particularly in patients with a history of cardiovascular conditions.
  • Risk of Bladder Cancer: Long-term use can potentially increase the risk of developing bladder cancer.
  • Bone Fractures: Individuals might face a heightened risk of fractures, particularly in women.

It’s crucial to monitor your health during treatment and consult a healthcare provider for regular assessments, including blood glucose and liver function tests.

Therapeutic Action: Mechanism of Action and Benefits

Actos 15 TAKEDA operates primarily by promoting insulin sensitivity in muscle and adipose tissues. This mechanism enhances the body’s ability to use insulin effectively, facilitating better glucose uptake from the bloodstream.

By incorporating Actos into a treatment plan, patients can experience a multitude of benefits, including:

  • Reduced Blood Glucose Levels: Effectively lowers fasting and postprandial blood sugar levels.
  • Improved Insulin Sensitivity: The drug enhances the body’s response to insulin, aiding metabolic processes.
  • Decreased Risk of Diabetic Complications: Better glucose control can potentially lower the risk of complications associated with diabetes.
  • Comprehensive Management Strategy: When combined with lifestyle changes (diet and exercise), it maximizes therapeutic outcomes.

Through consistent use, Actos contributes to a holistic approach in managing type 2 diabetes and promoting better overall health.

Actos 15 TAKEDA: Dosage Regimen and Treatment Course

The dosage of Actos 15 TAKEDA should be tailored to meet individual health needs while considering the severity of diabetes. The general guidelines for dosing include:

  • Initial Dosage: Typically, the starting dose is 15-30 mg per day, based on the patient’s condition and response.
  • Maintenance Dosage: The dosage may be adjusted between 15-45 mg per day to achieve optimal blood sugar control.
  • Administration: It can be taken once daily, with or without food, to maintain consistent blood levels.
  • Regular Monitoring: Patients are advised to undergo periodic monitoring to assess blood glucose levels and liver function.

Following the prescribed dosing regimen is crucial for the effective management of diabetes and minimizing the risk of side effects. Always consult your healthcare provider before making any changes to your medication schedule.

Additional information

Active substance

Pioglitazone

Acne

No

Water Retention

No

HBR

No

Hepatotoxicity

No

Aromatization

No

Lab Test

Monitoring blood glucose and liver function tests

Also known as

Pioglitazone hydrochloride

WAREHOUSE

International Warehouse 2

Blood pressure

Could potentially cause fluid retention which might increase blood pressure

Trade name

Actos

Storage conditions

Store at room temperature, protect from moisture and light

Chemical name

5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione

Formula

C19H20N2O3S

Substance class

Thiazolidinedione

Main action

Antidiabetic, insulin sensitizer

Half-life

3-7 hours

Dosage (medical)

Typically 15-45 mg per day

Dosage (sports)

Not applicable

Effects

Lowers blood glucose, increases insulin sensitivity

Side effects

Weight gain, edema, heart failure, increased risk of bladder cancer, bone fractures

Use in sports

Not typically used in sports

Manufacturer

Takeda

Reviews

There are no reviews yet.

Be the first to review “Actos 15 TAKEDA”